Ticker > Company >

Docmode Health Tech share price

Docmode Health Technologies Ltd.

NSE: DHTL SECTOR: Educational Institutions  10.79 K   2   0

91.10
+4.30 (4.95%)
NSE: 07 Oct 4:00 PM

Price Summary

Today's High

₹ 91.1

Today's Low

₹ 91.1

52 Week High

₹ 104.6

52 Week Low

₹ 36.9

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

28.63 Cr.

Enterprise Value

33.67 Cr.

No. of Shares

0.31 Cr.

P/E

0

P/B

3.43

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  26.58

CASH

1.79 Cr.

DEBT

6.82 Cr.

Promoter Holding

47.44 %

EPS (TTM)

₹  -6.46

Sales Growth

4.41%

ROE

-21.68 %

ROCE

-0.33%

Profit Growth

-1148.74 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.41%
3 Year49.81%
5 YearNA

Profit Growth

1 Year-1148.74%
3 Year-230.03%
5 YearNA

ROE%

1 Year-21.68%
3 Year20.38%
5 Year55.91%

ROCE %

1 Year-0.33%
3 Year18.12%
5 Year31.56%

Debt/Equity

0.8169

Price to Cash Flow

4.31

Interest Cover Ratio

-0.0304

CFO/PAT (5 Yr. Avg.)

4.87474048442907

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 47.44 61.16
Dec 2024 47.44 61.16
Sep 2024 47.44 61.16
Mar 2024 47.44 0.00
Feb 2024 47.44 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 49.8146525756422% for the Past 3 years.

 Limitations

  • The company has shown a poor profit growth of -230.033971506402% for the Past 3 years.
  • Company has low Interest coverage ratio of -0.0304.
  • The company is trading at a high EV/EBITDA of 139.6367.
  • Promoter pledging is high as 61.16%.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 7.1 12.42 32.88 40.01 41.77
Total Expenditure 6.23 10.54 29.13 38.12 42.46
Operating Profit 0.87 1.89 3.75 1.89 -0.69
Other Income 0 0.01 0.1 0.14 0.93
Interest 0.19 0.38 1.13 1.65 1.91
Depreciation 0.04 0.02 0.02 0.02 0.3
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.65 1.5 2.69 0.35 -1.97
Tax 0.09 0.58 0.74 0.15 0.06
Net Profit 0.55 0.92 1.95 0.19 -2.03
Adjusted EPS (Rs.) 3.15 5.26 8.5 0.62 -6.46

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.01 0.01 2.29 3.14 3.14
Total Reserves 0.46 1.38 1.19 7.24 5.21
Borrowings 0.66 3.37 4.42 4.38 1.12
Other N/C liabilities 0.1 0.31 0.34 0.48 0.44
Current liabilities 4.4 4.95 8.63 14.75 29.14
Total Liabilities 5.63 10.02 16.87 29.99 39.06
Assets
Net Block 0.03 0.06 0.05 0.97 1.22
Capital WIP 0 0 0 0 0
Intangible WIP 0.12 0.44 2.03 8.5 11.6
Investments 0 1.1 1.1 1.1 1.21
Loans & Advances 0.08 0.04 0.07 0.21 0.22
Other N/C Assets 0 0 0 0 0
Current Assets 5.39 8.38 13.63 19.21 24.82
Total Assets 5.63 10.02 16.87 29.99 39.06
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.65 1.5 2.69 0.35 -1.97
Adjustment 0.38 0.63 1.26 1.85 2.25
Changes in Assets & Liabilities -1.52 -4.08 -4.79 2.29 6.5
Tax Paid 0 -0.1 0.01 0.01 -0.13
Operating Cash Flow -0.5 -2.05 -0.83 4.49 6.64
Investing Cash Flow -0.13 -1.52 -1.57 -7.55 -3.67
Financing Cash Flow 0.84 3.41 2.65 5.76 -4.27
Net Cash Flow 0.21 -0.17 0.25 2.7 -1.3

Corporate Actions

Investors Details

PARTICULARS Feb 2024% Mar 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 47.44 47.44 47.44 47.44 47.44
hans albert lewis 23.71 23.71 23.71 23.71 23.71
kenneth paul lewis 0.01 0.01 0.01 0.01 0.01
paulson paul thazhathedat... 23.71 23.71 23.71 23.71 23.71
PARTICULARS Feb 2024% Mar 2024% Sep 2024% Dec 2024% Mar 2025%
investors 52.56 52.56 52.56 52.56 52.56
aalok bansidhar pathak 12.73 12.73 12.73 12.73 12.73
anil khanna 12.77 12.77 12.77 12.77 12.77
nikhil r jain - - 3.21 3.21 3.21
ramesh jain - - - - 2.11
ramesh kumar jain - - 2.55 2.55 2.95
vinod danmal kothari - - - - 1.27
aditya joshi - 1.93 1.17 1.17 -
rikhav securities limited... 1.37 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Docmode Health Tech Stock Price Analysis and Quick Research Report. Is Docmode Health Tech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Docmode Health Tech. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Docmode Health Tech has a PE ratio of -14.0940947135542 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Docmode Health Tech has ROA of -5.8842% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Docmode Health Tech has a Current ratio of 0.8519.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Docmode Health Tech has a ROE of -21.6821%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Docmode Health Tech has a Debt to Equity ratio of 0.8169 which means that the company has low proportion of debt in its capital.

  • Sales growth: Docmode Health Tech has reported revenue growth of 4.4132% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Docmode Health Tech for the current financial year is -1.64843714465597%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Docmode Health Tech is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Docmode Health Tech is Rs -6.4637. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Docmode Health Tech in Ticker for free. Also, one can get the intrinsic value of Docmode Health Tech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Docmode Health Tech FAQs

Q1. What is Docmode Health Tech share price today?
Ans: The current share price of Docmode Health Tech is Rs 91.1.

Q2. What is the market capitalisation of Docmode Health Tech?
Ans: Docmode Health Tech has a market capitalisation of Rs 28.630908 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Docmode Health Tech?
Ans: The PE ratio of Docmode Health Tech is -14.0940947135542 and the P/B ratio of Docmode Health Tech is 3.42749217433181, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Docmode Health Tech share?
Ans: The 52-week high share price of Docmode Health Tech is Rs 104.6, and the 52-week low share price of Docmode Health Tech is Rs 36.9.

Q5. Does Docmode Health Tech pay dividends?
Ans: Currently, Docmode Health Tech does not pay dividends. Dividend yield of Docmode Health Tech is around 0%.

Q6. What are the face value and book value of Docmode Health Tech shares?
Ans: The face value of Docmode Health Tech shares is Rs 10, while the book value per share of Docmode Health Tech is around Rs 26.5792. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Docmode Health Tech?
Ans: Docmode Health Tech has a total debt of Rs 6.8236 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Docmode Health Tech?
Ans: The ROE of Docmode Health Tech is -21.6821% and ROCE of Docmode Health Tech is -0.3345%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Docmode Health Tech a good buy for the long term?
Ans: The Docmode Health Tech long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Docmode Health Tech undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Docmode Health Tech appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Docmode Health Tech’s financials?
Ans: You can review Docmode Health Tech’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Docmode Health Tech
X